carbazilquinone has been researched along with Leukemia, Lymphoid in 1 studies
Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.
Leukemia, Lymphoid: Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshikawa, H | 1 |
| Sao, H | 1 |
| Tahara, T | 1 |
| Akao, Y | 1 |
| Yoshikawa, S | 1 |
1 other study available for carbazilquinone and Leukemia, Lymphoid
| Article | Year |
|---|---|
[A case of refractory acute lymphocytic leukemia who achieved a complete remission by mitoxantrone].
Topics: Adult; Anthraquinones; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Cyclophospha | 1984 |